Veradermics MANE Financing Cash Flow
Financing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Veradermics in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.
The official record: Veradermics ’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Veradermics 's financing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Veradermics 's financing cash flow?
- Veradermics (MANE) reported financing cash flow of $269.11M in Q1 2026.
- How has Veradermics 's financing cash flow changed year-over-year?
- Veradermics 's financing cash flow increased by 3095.0% year-over-year, from $8.42M to $269.11M.
- What does financing cash flow mean?
- The net amount of cash generated from or used for financing activities like issuing stock or borrowing money.
- How do you interpret financing cash flow?
- Positive values indicate capital inflows from investors or lenders, while negative values suggest debt repayment or share buybacks.
- How does financing cash flow compare across companies?
- Common across all public companies; high variability in early-stage biotech due to frequent equity raises.